Internationally recognized expert in the field of influenza viral genomics and diagnostics. Responsible for Manufacturing and Maintaining 6 FDA approved diagnostic assays including CDC’s Influenza A/B SARS-CoV-2 Multiplex Assay. Sequenced and published first RNA genome by sequencing the viral RNA directly. Team is one of the largest producers of influenza genomic data in the world.
The COVID-19 pandemic is driving the unprecedented transformation of the global medical research ecosystem through the search for effective new therapeutics that can help ease symptoms and prevent death among COVID-19 patients.